Activity and safety of sunitinib in patients with advanced radioactive iodine-refractory differentiated thyroid carcinoma in clinical practice

@article{Diez2014ActivityAS,
  title={Activity and safety of sunitinib in patients with advanced radioactive iodine-refractory differentiated thyroid carcinoma in clinical practice},
  author={Juan Jos{\'e} Rodrı́guez Diez and Pedro Iglesias and Teresa Alonso and Enrique Grande},
  journal={Endocrine},
  year={2014},
  volume={48},
  pages={582-588}
}
Our aim was to evaluate the effectiveness of off-label use of sunitinib in patients with advanced differentiated thyroid carcinoma (DTC) refractory to radioactive iodine (RAI) therapy. We performed a retrospective analysis of patients treated in the setting of clinical practice in a University General Hospital. Eleven consecutive patients (5 women, 6 men… CONTINUE READING